Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-1,99
KB0,90
PKN65,1165,142,13
Msft-0,17
Nokia3,29053,2965-1,02
IBM0,08
Mercedes-Benz Group AG73,8573,870,39
PFE-0,11
28.03.2024 22:22:39
Indexy online
AD Index online
select
AD Index online
 

  • 26.03.2024 14:40:13
Grifols -A- (Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
8,25 -0,10 -0,01 5 746
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 28.03.2024
Popis společnosti
Obecné informace
Název společnostiGrifols SA
TickerGRF
TickerGRF.P
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Preference Shares Class B
RICGRLSbn.MC
RICGRLS.MC
ISINES0171996087
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 23 744
Akcie v oběhu k 31.12.2023 679 092 279
MěnaEUR
Kontaktní informace
UliceC/ Jesus y Maria, 6
MěstoBARCELONA
PSČ08022
ZeměSpain
Kontatní osoba 
Funkce kontaktní osoby 
Telefon34 935 710 000
Fax34935710267

Business Summary: Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Grifols SA revenues increased 9% to EUR6.59B. Net income decreased 72% to EUR59.3M. Revenues reflect Bioscience segment increase of 11% to EUR5.56B, Bio Supplies segment increase of 10% to EUR160M, Rest of the World segment increase of 22% to EUR1.44B, European Union segment increase of 26% to EUR893.1M. Net income was offset by Selling/General/Admin. Expense - Balanci increase of 16% to EUR730.8M (expense).
Odvětvová klasifikace
TRBC2012Biopharmaceuticals
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSBlood and Organ Banks
NAICSOffices of Other Holding Companies
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007In-Vitro Diagnostic Substance Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Offices of Other Holding Companies
NAICS2007Blood & Organ Banks
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997InVitro Diagnostic Substance Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Offices of Other Holding Companies
NAICS1997Blood and Organ Banks
NAICS1997Surgical and Medical Instrument Manufacturing
SICBiological Prod's Not Diagnostic
SICDiagnostic Substances
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICHealth And Allied Services, Nec
SICHolding Companies, Nec



  • Poslední aktualizace: 28.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the Board, Chief Executive OfficerThomas Glanzmann6508.05.202321.02.2023
Chief Financial OfficerAlfredo Arroyo Guerra-
President - Plasma ProcurementJordi Balsells Valls-01.01.2022
President - Bio SuppliesAlberto Grifols Roura-
President - DiagnosticAntonio Martinez Martinez-
Chief Human Resource OfficerMontserrat Gaja Llamas-
Senior Vice President - Strategy & COO OfficeLluis Pons Gomez-01.01.2022
Chief Digital Information OfficerMiguel Angel Louzan Garcia-01.01.2023
Chief Scientific Innovation OfficerJoerg Schuettrumpf-01.01.2023
Vice President - Healthcare SolutionsFrancisco Javier Guix Huguet-01.01.2022